Angus Grant - Net Worth and Insider Trading
Angus Grant Net Worth
The estimated net worth of Angus Grant is at least $162,892 dollars as of 2024-09-13. Angus Grant is the EVP, Business Development of Teva Pharmaceutical Industries Ltd and owns about 8,848 shares of Teva Pharmaceutical Industries Ltd (TEVA) stock worth over $162,892. Details can be seen in Angus Grant's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Angus Grant has not made any transactions after 2024-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Angus Grant
Angus Grant Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Angus Grant owns 1 companies in total, including Teva Pharmaceutical Industries Ltd (TEVA) .
Click here to see the complete history of Angus Grant’s form 4 insider trades.
Insider Ownership Summary of Angus Grant
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Ltd | 2024-08-09 | EVP & Business Development |
Angus Grant Latest Holdings Summary
Angus Grant currently owns a total of 1 stock. Angus Grant owns 8,848 shares of Teva Pharmaceutical Industries Ltd (TEVA) as of August 9, 2024, with a value of $162,892.
Latest Holdings of Angus Grant
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Ltd | 2024-08-09 | 8,848 | 18.41 | 162,892 |
Holding Weightings of Angus Grant
Angus Grant Form 4 Trading Tracker
According to the SEC Form 4 filings, Angus Grant has made a total of 1 transactions in Teva Pharmaceutical Industries Ltd (TEVA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Teva Pharmaceutical Industries Ltd is the sale of 4,065 shares on August 9, 2024, which brought Angus Grant around $70,243.
Insider Trading History of Angus Grant
- 1
Angus Grant Trading Performance
Angus Grant Ownership Network
Angus Grant Owned Company Details
What does Teva Pharmaceutical Industries Ltd do?
Who are the key executives at Teva Pharmaceutical Industries Ltd?
Angus Grant is the EVP & Business Development of Teva Pharmaceutical Industries Ltd. Other key executives at Teva Pharmaceutical Industries Ltd include Exec. VP & European Commercial Richard Daniell , See "Remarks" Eric A Hughes , and Chief Accounting Officer Amir Weiss .
Teva Pharmaceutical Industries Ltd (TEVA) Insider Trades Summary
Over the past 18 months, Angus Grant made 1 insider transaction in Teva Pharmaceutical Industries Ltd (TEVA) with a net sale of 4,065. Other recent insider transactions involving Teva Pharmaceutical Industries Ltd (TEVA) include a net sale of 263,933 shares made by Richard Daniell , a net sale of 130,384 shares made by Eric A Hughes , and a net sale of 61,882 shares made by Amir Weiss .
In summary, during the past 3 months, insiders sold 691,605 shares of Teva Pharmaceutical Industries Ltd (TEVA) in total and bought 0 shares, with a net sale of 691,605 shares. During the past 18 months, 1,467,557 shares of Teva Pharmaceutical Industries Ltd (TEVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,467,557 shares.
Teva Pharmaceutical Industries Ltd (TEVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Teva Pharmaceutical Industries Ltd Insider Transactions
Angus Grant Mailing Address
Above is the net worth, insider trading, and ownership report for Angus Grant. You might contact Angus Grant via mailing address: C/o Teva, 5 Basel Street, P.o. Box 3190, Petach Tikva L3 4951033.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
